Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.
Scott B. Shappell, MD, PhD
Advertisement
Articles by Scott B. Shappell, MD, PhD
Discovery of the prostate carcinoma-specific gene has led to the development of a promising urine-based laboratory test for the disease.
Advertisement
Latest Updated Articles
- Low-risk prostate cancer well managed with active surveillance
Published: November 1st 2009 | Updated:
- Clinical use of urine PCA3 mRNA testing
Published: September 1st 2009 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
MRI, myths, and precision: Stacy Loeb, MD, discusses modern prostate cancer screening
2
Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer
3
Dual targeting of PAM and AR pathways yields encouraging results in mCRPC
4
Suzanne Merrill, MD, on integrating ICIs into clinical practice for NMIBC
5
